These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Cannabinoids inhibit human keratinocyte proliferation through a non-CB1/CB2 mechanism and have a potential therapeutic value in the treatment of psoriasis. Wilkinson JD, Williamson EM. J Dermatol Sci; 2007 Feb; 45(2):87-92. PubMed ID: 17157480 [Abstract] [Full Text] [Related]
6. Binding affinity and agonist activity of putative endogenous cannabinoids at the human neocortical CB1 receptor. Steffens M, Zentner J, Honegger J, Feuerstein TJ. Biochem Pharmacol; 2005 Jan 01; 69(1):169-78. PubMed ID: 15588725 [Abstract] [Full Text] [Related]
7. Atypical cannabinoid stimulates endothelial cell migration via a Gi/Go-coupled receptor distinct from CB1, CB2 or EDG-1. Mo FM, Offertáler L, Kunos G. Eur J Pharmacol; 2004 Apr 05; 489(1-2):21-7. PubMed ID: 15063151 [Abstract] [Full Text] [Related]
10. Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB1, CB2 and CB1/CB2 heteromer receptors. Navarro G, Varani K, Lillo A, Vincenzi F, Rivas-Santisteban R, Raïch I, Reyes-Resina I, Ferreiro-Vera C, Borea PA, Sánchez de Medina V, Nadal X, Franco R. Pharmacol Res; 2020 Sep 05; 159():104940. PubMed ID: 32470563 [Abstract] [Full Text] [Related]
11. The pharmacology of cannabinoid receptors and their ligands: an overview. Pertwee RG. Int J Obes (Lond); 2006 Apr 05; 30 Suppl 1():S13-8. PubMed ID: 16570099 [Abstract] [Full Text] [Related]
12. Endocannabinoids as positive or negative factors in hematopoietic cell migration and differentiation. Patinkin D, Milman G, Breuer A, Fride E, Mechoulam R. Eur J Pharmacol; 2008 Oct 24; 595(1-3):1-6. PubMed ID: 18778813 [Abstract] [Full Text] [Related]
13. Differential CB1 and CB2 cannabinoid receptor-inotropic response of rat isolated atria: endogenous signal transduction pathways. Sterin-Borda L, Del Zar CF, Borda E. Biochem Pharmacol; 2005 Jun 15; 69(12):1705-13. PubMed ID: 15885656 [Abstract] [Full Text] [Related]
16. Pharmacology of cannabinoids. Grotenhermen F. Neuro Endocrinol Lett; 2004 Jun 15; 25(1-2):14-23. PubMed ID: 15159677 [Abstract] [Full Text] [Related]
17. Cannabinoids and the skeleton: from marijuana to reversal of bone loss. Bab I, Zimmer A, Melamed E. Ann Med; 2009 Jun 15; 41(8):560-7. PubMed ID: 19634029 [Abstract] [Full Text] [Related]
18. Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures--a short review. Svízenská I, Dubový P, Sulcová A. Pharmacol Biochem Behav; 2008 Oct 15; 90(4):501-11. PubMed ID: 18584858 [Abstract] [Full Text] [Related]
19. Basic neuroanatomy and neuropharmacology of cannabinoids. Breivogel CS, Sim-Selley LJ. Int Rev Psychiatry; 2009 Apr 15; 21(2):113-21. PubMed ID: 19367505 [Abstract] [Full Text] [Related]
20. Binding thermodynamics at the human cannabinoid CB1 and CB2 receptors. Merighi S, Simioni C, Gessi S, Varani K, Borea PA. Biochem Pharmacol; 2010 Feb 01; 79(3):471-7. PubMed ID: 19766600 [Abstract] [Full Text] [Related] Page: [Next] [New Search]